Taisho Pharmaceutical Holdings Co Ltd (TAISF)
OTHER OTC:TAISF
US Market
Holding TAISF?
Track your performance easily

Taisho Pharmaceutical Holdings Co (TAISF) Income Statement

4 Followers

Taisho Pharmaceutical Holdings Co Income Statement

Last quarter (Q3 2022), Taisho Pharmaceutical Holdings Co's total revenue was $83.15B, an increase of 18.97% from the same quarter last year. In Q3, Taisho Pharmaceutical Holdings Co's net income was $10.02B. See Taisho Pharmaceutical Holdings Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Mar 22Mar 21Mar 20Mar 19Mar 18
Total Revenue
$ 220.37B$ 268.20B$ 282.04B$ 288.72B$ 261.37B$ 280.14B
Cost of Revenue
$ 86.91B$ 104.37B$ 106.05B$ 108.39B$ 91.21B$ 97.15B
Gross Profit
$ 133.46B$ 163.83B$ 175.99B$ 180.33B$ 170.16B$ 182.98B
Operating Expense
$ 113.68B$ 153.09B$ 156.02B$ 159.20B$ 138.95B$ 146.01B
Operating Income
$ 19.78B$ 10.74B$ 19.96B$ 21.14B$ 31.21B$ 36.98B
Net Non Operating Interest Income Expense
$ 949.00M$ 1.17B$ 1.53B$ 3.65B$ 4.95B$ 5.00B
Other Income Expense
------
Pretax Income
$ 27.72B$ 21.40B$ 22.98B$ 29.77B$ 64.48B$ 48.07B
Tax Provision
$ 6.21B$ 6.45B$ 7.78B$ 8.24B$ 14.66B$ 14.70B
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ 19.92B$ 13.12B$ 13.32B$ 20.17B$ 48.59B$ 31.68B
Basic EPS
$ 243.10$ 161.12$ 166.84$ 257.23$ 608.80$ 396.54
Diluted EPS
$ 242.79$ 160.93$ 166.63$ 256.93$ 608.22$ 396.20
Basic Average Shares
$ 245.93M$ 81.44M$ 79.82M$ 79.81M$ 79.82M$ 79.89M
Diluted Average Shares
$ 246.24M$ 81.54M$ 79.91M$ 79.91M$ 79.89M$ 79.96M
Dividend Per Share
$ 50.00$ 100.00$ 50.00$ 110.00$ 110.00$ 110.00
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 200.59B$ 257.46B$ 262.07B$ 267.58B$ 230.16B$ 243.16B
Net Income From Continuing And Discontinued Operation
$ 19.92B$ 13.12B$ 13.32B$ 20.17B$ 48.59B$ 31.68B
Normalized Income
$ 20.06B$ 11.03B$ 15.31B$ 16.36B$ 30.32B$ 27.56B
Interest Expense
$ 144.00M$ 170.00M$ 156.00M$ 118.00M$ 2.00M$ 2.00M
EBIT
$ 27.86B$ 21.57B$ 23.13B$ 29.89B$ 64.49B$ 48.07B
EBITDA
$ 27.86B$ 44.64B$ 45.17B$ 46.91B$ 75.78B$ 59.45B
Currency in USD

Taisho Pharmaceutical Holdings Co Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis